Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial
Margolese, Richard G, Prof, Cecchini, Reena S, PhD, Julian, Thomas B, Prof, Ganz, Patricia A, Prof, Costantino, Joseph P, DrPH, Vallow, Laura A, MD, Albain, Kathy S, Prof, Whitworth, Patrick W, MD, Cianfrocca, Mary E, DO, Brufsky, Adam M, Prof, Gross, Howard M, MD, Soori, Gamini S, Prof, Hopkins, Judith O, MD, Fehrenbacher, Louis, MD, Sturtz, Keren, MD, Wozniak, Timothy F, MD, Seay, Thomas E, MD, Mamounas, Eleftherios P, MD, Wolmark, Norman, Prof
Published in The Lancet (British edition) (27.02.2016)
Published in The Lancet (British edition) (27.02.2016)
Get full text
Journal Article
Patient-reported outcomes with anastrozole versus tamoxifen for postmenopausal patients with ductal carcinoma in situ treated with lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial
Ganz, Patricia A, Prof, Cecchini, Reena S, PhD, Julian, Thomas B, Prof, Margolese, Richard G, Prof, Costantino, Joseph P, DrPH, Vallow, Laura A, MD, Albain, Kathy S, Prof, Whitworth, Patrick W, MD, Cianfrocca, Mary E, DO, Brufsky, Adam M, Prof, Gross, Howard M, MD, Soori, Gamini S, Prof, Hopkins, Judith O, MD, Fehrenbacher, Louis, MD, Sturtz, Keren, MD, Wozniak, Timothy F, MD, Seay, Thomas E, MD, Mamounas, Eleftherios P, MD, Wolmark, Norman, Prof
Published in The Lancet (British edition) (27.02.2016)
Published in The Lancet (British edition) (27.02.2016)
Get full text
Journal Article